Expert Testimony After the Rule 702 Amendments: Where Are We Now? (Presented by The Federal Bar Association Annual Meeting & Convention 2025 sponsor Norton Rose Fulbright US LLP)

Charmaine Harris
Gene Hummel
William Childs
Charmaine Harris | Norton Rose Fulbright US LLP
Gene Hummel | Norton Rose Fulbright US LLP
William Childs | Bowman and Brooke LLP
Live Video-Broadcast: December 3, 2025

1 hour CLE

Tuition: $395.00
Subscribe to myLawCLEs All-Acces Pass...
Get this course, plus over 1,000+ of live webinars.
Learn More
This program is only available to All-Access Pass Members.
All-Access Pass

Free access to all CLE programs w/active subscription. Annual subscription only $395/yr.

Training 5 or more people?

Sign-up for a law firm subscription plan and each attorney in the firm receives free access to all CLE Programs

Program Summary

This panel will explore the practical impact of the 2023 amendments to Federal Rule of Evidence 702, which clarify the trial court's role as gatekeeper for expert testimony. The panel will review how courts across the country have applied the revised rule and whether the changes have meaningfully altered judicial behavior. With decisions like Sprafka expected from the Eighth Circuit by fall 2025, the panel will provide timely insights on the evolving landscape of expert admissibility in federal court.

Presented by The Federal Bar Association Annual Meeting & Convention 2025 sponsor Norton Rose Fulbright US LLP

Key topics to be discussed:

  • Understand the substantive changes to Rule 702 and their intended impact
  • Review case law developments since the amendment across various jurisdictions
  • Identify how litigators should adapt expert strategy in light of heightened admissibility scrutiny

Date / Time: December 3, 2025

  • 2:00 pm – 3:00 pm Eastern
  • 1:00 pm – 2:00 pm Central
  • 12:00 pm – 1:00 pm Mountain
  • 11:00 am – 12:00 pm Pacific

Closed-captioning available

Speakers

Charmaine Harris | Norton Rose Fulbright US LLP

Charmaine K. Harris’s practice focuses on medical device, products liability defense and other complex litigation. She is a lead associate for a Fortune 500 Company defending its product liability and premises liability claims arising in state and federal courts nationwide. In that role, Charmaine conducts discovery depositions, represents the client at mediations and negotiates settlements. Additionally, Charmaine is also experienced in defending asbestos and employment-related disputes. Prior to law school, Charmaine was a senior mechanical design engineer in Medtronic, Inc.’s Neuromodulation business unit. As a medical device engineer, she designed, tested and improved spinal cord stimulation devices. She is a named inventor on five patents for these devices. Her prior career as a medical device engineer gives her a sophisticated understanding of technologically complicated cases.

 

Mediator, Gene Hummel | Norton Rose Fulbright US LLP

Gene Hummel represents and counsels businesses nationwide in a variety of civil litigation matters including products liability, contract disputes, business torts and other complex litigation. He has previous experience in construction and employment litigation in which he represented clients in midsized and large matters including commercial disputes, contract disputes and construction defect liability defense. Additionally, Gene has an active pro bono practice, representing asylum seekers as well as tenants in housing disputes in both state and federal courts, including the 8th Circuit.

 

William Childs | Bowman and Brooke LLP

Bill Childs is a national attorney with nearly 25 years of experience defending clients in the pharmaceutical and medical device industries. His practice focuses on pharmaceutical mass tort, patent, commercial and other litigation, bringing extensive experience in handling complex, high-stakes cases. His Fortune 500 in-house experience, including serving as litigation counsel for two major corporations, gives him a unique perspective on managing high-stakes litigation from both outside and in-house counsel roles. This dual insight allows him to effectively navigate complex legal and regulatory challenges while aligning legal strategy with business objectives. Bill has extensive experience defending large-volume mass torts and working closely with technical experts. He routinely works with company and expert witnesses, including sales representatives, FDA experts, epidemiologists and physicians of all specialties. His ability to dive deep into the company story, medicine and science behind claims allows him to form a complete view of complex medical and regulatory issues. Bill thrives on organizing complicated evidence into key themes supported by the facts developed from witness interviews, depositions and key document review.

His ability to quickly understand complex issues and cases translates into strategic and comprehensive case chronologies. Beyond mass tort litigation, Bill has handled a wide range of litigation matters across various industries. Bill also handles a range of other types of litigation. He has represented a medical device manufacturer in a trade secret matter, an educational tablet maker in warranty matters, an all-terrain vehicle manufacturer in warranty matters (including trying a case to verdict) and a highway safety equipment manufacturer in personal injury litigation.

Agenda

I. Review of the substantive changes to Federal Rule of Evidence 702 and their impact | 2:00pm – 2:20pm

II. Discuss the Eighth Circuit’s Sprafka ruling (expected fall 2025) | 2:20pm – 2:40pm

III. Discuss strategies for navigating heightened expert scrutiny | 2:40pm – 3:00pm

Credits

Alaska

Approved for CLE Credits
1 General

Our programs are CLE-eligible through Alaska’s recognition of multi-jurisdictional reciprocity.
Alabama

Pending CLE Approval
1 General

Arkansas

Approved for CLE Credits
1 General

Arizona

Approved for CLE Credits
1 General

California

Approved for CLE Credits
1 General

Colorado

Pending CLE Approval
1 General

Connecticut

Approved for CLE Credits
1 General

District of Columbia

No MCLE Required
1 CLE Hour(s)

Delaware

Pending CLE Approval
1 General

Florida

Approved via Attorney Submission
1 General Hours

Receive CLE credit in Florida via attorney submission.
Georgia

Pending CLE Approval
1 General

Hawaii

Approved for CLE Credits
1.2 General

Iowa

Pending CLE Approval
1 General

Idaho

Pending CLE Approval
1 General

Illinois

Pending CLE Approval
1 General

Indiana

Pending CLE Approval
1 General

Kansas

Pending CLE Approval
1 Substantive

Kentucky

Pending CLE Approval
1 General

Louisiana

Pending CLE Approval
1 General

Massachusetts

No MCLE Required
1 CLE Hour(s)

Maryland

No MCLE Required
1 CLE Hour(s)

Maine

Pending CLE Approval
1 General

Michigan

No MCLE Required
1 CLE Hour(s)

Minnesota

Pending CLE Approval
1 General

Missouri

Approved for CLE Credits
1.2 General

Mississippi

Pending CLE Approval
1 General

Montana

Pending CLE Approval
1 General

North Carolina

Pending CLE Approval
1 General

North Dakota

Approved for CLE Credits
1 General

Our programs are CLE-eligible through North Dakota’s recognition of multi-jurisdictional reciprocity. Section 1, Policy 1.14
Nebraska

Pending CLE Approval
1 General

myLawCLE reports attendance to Nebraska on each attorney’s behalf for all programs. Please do not self-report.
New Hampshire

Approved for CLE Credits
60 General minutes

As of July 1, 2014, the NHMCLE Board no longer provides pre- or post-approval of courses. Attendees must self-determine whether a program is eligible for credit, and self-report their attendance online at www.nhbar.org, based on qualification provisions of Rule 53.
New Jersey

Approved for CLE Credits
1.2 General

Our programs are CLE-eligible through New Jersey’s recognition of multi-jurisdictional reciprocity, except for the courses required under BCLE Reg. 201:2
New Mexico

Approved for CLE Credits
1 General

Nevada

Pending CLE Approval
1 General

New York

Approved for CLE Credits
1.2 General

Our programs are CLE-eligible through New York’s Approved Jurisdiction Group “B”.
Ohio

Pending CLE Approval
1 General

Oklahoma

Pending CLE Approval
1 General

Oregon

Pending CLE Approval
1 General

Pennsylvania

Approved for CLE Credits
1 General

Rhode Island

Pending CLE Approval
1 General

South Carolina

Pending CLE Approval
1 General

South Dakota

No MCLE Required
1 CLE Hour(s)

Tennessee

Pending CLE Approval
1 General

Texas

Approved for CLE Credits
1 General

Utah

Pending CLE Approval
1 General

Virginia

Not Eligible
1 General Hours

Vermont

Approved for CLE Credits
1 General

Washington

Approved via Attorney Submission
1 Law & Legal Hours

Receive CLE credit in Washington via attorney submission.
Wisconsin

Pending CLE Approval
1 General

West Virginia

Pending CLE Approval
1.2 General

Wyoming

Pending CLE Approval
1 General

#1 CLE Access Program

  • Over 1,000 Live CLE Webinars each year
  • All CLE webinars broadcasted in last 12 months
  • Programs covering over 35 practice areas
  • Hot topics & changes in the law
  • All formats: Live, Replay, and On-demand
  • Accreditation in every state

Access every CLE webinar,
every format, all year long!

myLawCLE All-Access Pass

only $395 yearly


Register Now

#1 CLE Access Program

  • Over 1,000 Live CLE Webinars each year
  • All CLE webinars broadcasted in last 12 months
  • Programs covering over 35 practice areas
  • Hot topics & changes in the law
  • All formats: Live, Replay, and On-demand
  • Accreditation in every state

Access every CLE webinar,
every format, all year long!

myLawCLE All-Access Pass

only $395 yearly


More CLE Webinars
Upcoming CLE Webinars
Using AI in Your Law Practice: A Step-by-Step Guide
Using AI in Your Law Practice: A Step-by-Step Guide Thu, November 20, 2025
On-Demand
Live Replay
Abating Tax Penalties (2025 Edition)
Abating Tax Penalties (2025 Edition) Tue, November 25, 2025
On-Demand
Live Replay
Rules and Sanctions Related to Gen AI in Law
Rules and Sanctions Related to Gen AI in Law Fri, December 5, 2025
Live Webcast
Digital Evidence and Technology in MDL Litigation
Digital Evidence and Technology in MDL Litigation Wed, December 10, 2025
Live Webcast
A, B, C’s of Revocable and Irrevocable Trusts
A, B, C’s of Revocable and Irrevocable Trusts Thu, December 11, 2025
Live Webcast
Litigation CLE Webinars